← Association for Accessible Medicines
FDANonrulemakingFDA-2013-D-1464

Draft Guidance for Industry on Bioequivalence Studies with Pharmacokinetic Endpoints for Drugs Submitted under an ANDA; Availability

RIN
—
Last modified
May 29, 2026
Comment window
closed 1740d ago
Association for Accessible Medicines filings
1

Activity

Association for Accessible Medicines filed 1 comment on this docket between Oct 25, 2021 and Oct 25, 2021. 0 other organizations filed here. The comment window closed 1740d ago.

What Association for Accessible Medicines filed (1)

Oct 25, 2021· Comment from Association for Accessible Medicines (AAM)· FDA-2013-D-1464-0019

Comments from The Association for Accessible Medicines (AAM) regarding Docket FDA-2013-D-1464: Bioequivalence Studies with Pharmacokinetic Endpoints for Drugs Submitted Under an ANDA Guidance for Industry.

View on regulations.gov →

Abstract

No abstract recorded.

View on regulations.gov →

Co-filers (0)

See everyone who commented →